Brookwood Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.73M Buy
3,111
+78
+3% +$79.7K 0.42% 47
2026
Q1
$2.79M Sell
3,033
-665
-18% -$674K 0.34% 68
2025
Q4
$3.97M Buy
3,698
+883
+31% +$844K 0.48% 36
2025
Q3
$2.15M Sell
2,815
-1,446
-34% -$1.08M 0.28% 62
2025
Q2
$3.32M Buy
4,261
+1,549
+57% +$1.2M 0.54% 32
2025
Q1
$2.24M Buy
+2,712
New +$2.26M 0.38% 39

Other funds holding LLY

Brookwood Investment Group's LLY Position: Q2 2026 in Review

Brookwood Investment Group increased its Eli Lilly (LLY) stake by 2.6% in Q2 2026, buying an estimated $79.7K and bringing the position to 3,111 shares worth $3.73M. The position accounts for 0.42% of the portfolio, ranked #47.

Brookwood Investment Group first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.97M in Q4 2025. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Brookwood Investment Group held 3,111 shares of Eli Lilly worth $3.73M as of Q2 2026.
  • Brookwood Investment Group bought 78 Eli Lilly shares in Q2 2026, an estimated $79.7K.
  • Eli Lilly made up 0.42% of Brookwood Investment Group's portfolio in Q2 2026, its #47 holding.
  • Brookwood Investment Group first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • Brookwood Investment Group's Eli Lilly position peaked at $3.97M in Q4 2025.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Brookwood Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.